{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:02:38Z","timestamp":1793757758479,"version":"4.6.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s10096-023-04688-5","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T11:02:25Z","timestamp":1698058945000},"page":"1531-1535","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Severe acute herpes virus type 2 primo-infection and its association with anti-type 1 interferon autoantibodies"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4524-9064","authenticated-orcid":false,"given":"Martin","family":"Martinot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Gravier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Mohseni-Zadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Fabien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Laurent","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Puel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goncalves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,23]]},"reference":[{"issue":"1","key":"4688_CR1","doi-asserted-by":"publisher","first-page":"e114989","DOI":"10.1371\/journal.pone.0114989","volume":"10","author":"KJ Looker","year":"2015","unstructured":"Looker KJ, Magaret AS, Turner KM, Vickerman P, Gottlieb SL, Newman LM (2015) Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PLoS ONE 10(1):e114989","journal-title":"PLoS ONE"},{"issue":"10265","key":"4688_CR2","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1016\/S0140-6736(20)32388-6","volume":"396","author":"VWY Lai","year":"2020","unstructured":"Lai VWY, Meher-Homji Z, Liu F, Sasadeusz J (2020) Primary herpes simplex virus type 2 hepatitis diagnosed during laparoscopy. Lancet 396(10265):e90","journal-title":"Lancet"},{"issue":"4","key":"4688_CR3","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1128\/JCM.44.4.1584-1586.2006","volume":"44","author":"T Czartoski","year":"2006","unstructured":"Czartoski T, Liu C, Koelle DM, Schmechel S, Kalus A, Wald A (2006) Fulminant, acyclovir-resistant, herpes simplex virus type 2 hepatitis in an immunocompetent woman. J Clin Microbiol 44(4):1584\u20131586","journal-title":"J Clin Microbiol"},{"issue":"1","key":"4688_CR4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12872-018-0869-2","volume":"18","author":"T Yamamoto","year":"2018","unstructured":"Yamamoto T, Kenzaka T, Matsumoto M, Nishio R, Kawasaki S, Akita H (2018) A case report of myocarditis combined with hepatitis caused by herpes simplex virus. BMC Cardiovasc Disord 18(1):134","journal-title":"BMC Cardiovasc Disord"},{"key":"4688_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijid.2018.03.006","volume":"71","author":"A Sonpar","year":"2018","unstructured":"Sonpar A, Brown K, Chen J et al (2018) Dual infection in pregnancy: disseminated mycoplasma hominis and necrotizing herpes simplex 2 hepatitis. Int J Infect Dis 71:1\u20133","journal-title":"Int J Infect Dis"},{"issue":"6","key":"4688_CR6","first-page":"682","volume":"55","author":"M Yuasa","year":"2014","unstructured":"Yuasa M, Ishiwata K, Sugio T et al (2014) Herpes simplex virus type 2 fulminant hepatitis after umbilical cord blood transplantation for acute myeloid leukemia. Rinsho Ketsueki 55(6):682\u2013686","journal-title":"Rinsho Ketsueki"},{"issue":"11","key":"4688_CR7","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1093\/ndt\/gfm550","volume":"22","author":"A Ganner","year":"2007","unstructured":"Ganner A, Lee YM, Busche C et al (2007) Successful liver transplantation in a kidney and pancreas allograft recipient with fulminant herpes simplex virus type 2 hepatitis. Nephrol Dial Transplant 22(11):3334\u20133337","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"4688_CR8","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1002\/lt.20545","volume":"11","author":"P Ichai","year":"2005","unstructured":"Ichai P, Roque Afonso AM, Sebagh M et al (2005) Herpes simplex virus-associated acute liver failure: a difficult diagnosis with a poor prognosis. Liver Transpl 11(12):1550\u20131555","journal-title":"Liver Transpl"},{"issue":"2","key":"4688_CR9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3851\/IMP1922","volume":"17","author":"J Ambrosioni","year":"2012","unstructured":"Ambrosioni J, Kaiser L, Giostra E et al (2012) Herpes simplex virus load to monitor antiviral treatment after liver transplantation for acute herpetic hepatitis. Antivir Ther 17(2):401\u2013404","journal-title":"Antivir Ther"},{"key":"4688_CR10","doi-asserted-by":"publisher","first-page":"e932474","DOI":"10.12659\/AJCR.932474","volume":"22","author":"D Srinivasan","year":"2021","unstructured":"Srinivasan D, Kaul CM, Buttar AB, Nottingham FI, Greene JB (2021) Disseminated herpes simplex virus-2 (HSV-2) as a cause of viral hepatitis in an immunocompetent host. Am J Case Rep 22:e932474","journal-title":"Am J Case Rep"},{"issue":"35","key":"4688_CR11","doi-asserted-by":"publisher","first-page":"e27139","DOI":"10.1097\/MD.0000000000027139","volume":"100","author":"SM Chavez","year":"2021","unstructured":"Chavez SM, Poniachik JM, Urzua AM et al (2021) Acute liver failure due to herpes simplex virus: diagnostic clues and potential role of plasmapheresis: a case report. Medicine 100(35):e27139","journal-title":"Medicine"},{"issue":"4","key":"4688_CR12","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","volume":"50","author":"HM Lazear","year":"2019","unstructured":"Lazear HM, Schoggins JW, Diamond MS (2019) Shared and distinct functions of type I and type III interferons. Immunity 50(4):907\u2013923","journal-title":"Immunity"},{"key":"4688_CR13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3389\/fcimb.2019.00127","volume":"9","author":"EI Tognarelli","year":"2019","unstructured":"Tognarelli EI, Palomino TF, Corrales N, Bueno SM, Kalergis AM, Gonzalez PA (2019) Herpes simplex virus evasion of early host antiviral responses. Front Cell Infect Microbiol 9:127","journal-title":"Front Cell Infect Microbiol"},{"key":"4688_CR14","doi-asserted-by":"crossref","unstructured":"Zhang Q, Bastard P, Liu Z et al (2020) Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 370:eabd4570","DOI":"10.1126\/science.abd4570"},{"issue":"1","key":"4688_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13073-023-01173-8","volume":"15","author":"D Matuozzo","year":"2023","unstructured":"Matuozzo D, Talouarn E, Marchal A et al (2023) Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19. Genome Med 15(1):22","journal-title":"Genome Med"},{"key":"4688_CR16","doi-asserted-by":"crossref","unstructured":"Asano T, Boisson B, Onodi F et al (2021) X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19. Sci Immunol 6:eabl4348","DOI":"10.1126\/sciimmunol.abl4348"},{"key":"4688_CR17","doi-asserted-by":"crossref","unstructured":"Bastard P, Gervais A, Le Voyer T et al (2021) Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol 6:eabl4340","DOI":"10.1126\/sciimmunol.abl4340"},{"issue":"21","key":"4688_CR18","doi-asserted-by":"publisher","first-page":"e2200413119","DOI":"10.1073\/pnas.2200413119","volume":"119","author":"J Manry","year":"2022","unstructured":"Manry J, Bastard P, Gervais A et al (2022) The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies. Proc Natl Acad Sci U S A 119(21):e2200413119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4688_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ijid.2023.03.011","volume":"130","author":"X Wang","year":"2023","unstructured":"Wang X, Tang Q, Li H et al (2023) Autoantibodies against type I interferons in COVID-19 infection: a systematic review and meta-analysis. Int J Infect Dis 130:147\u2013152","journal-title":"Int J Infect Dis"},{"issue":"8","key":"4688_CR20","doi-asserted-by":"publisher","first-page":"e1327","DOI":"10.1002\/cti2.1327","volume":"10","author":"D Goncalves","year":"2021","unstructured":"Goncalves D, Mezidi M, Bastard P et al (2021) Antibodies against type I interferon: detection and association with severe clinical outcome in COVID-19 patients. Clin Transl Immunology 10(8):e1327","journal-title":"Clin Transl Immunology"},{"issue":"5","key":"4688_CR21","first-page":"282","volume":"78","author":"EM Jongbloed","year":"2020","unstructured":"Jongbloed EM, Hermans MAW, Wabbijn M, van Kampen JJA, van Laar JAM (2020) HLH caused by an HSV-2 infection: a case report and review of the literature. Neth J Med 78(5):282\u2013285","journal-title":"Neth J Med"},{"key":"4688_CR22","doi-asserted-by":"crossref","unstructured":"Bastard P, Rosen LB, Zhang Q et al (2020) Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 370:eabd4585","DOI":"10.1126\/science.abd4585"},{"key":"4688_CR23","doi-asserted-by":"crossref","unstructured":"Zhang Q, Pizzorno A, Miorin L et al (2022) Autoantibodies against type I IFNs in patients with critical influenza pneumonia. J Exp Med 219(11):e20220514","DOI":"10.1084\/jem.20220514"},{"issue":"5","key":"4688_CR24","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/infdis\/150.5.707","volume":"150","author":"B Pozzetto","year":"1984","unstructured":"Pozzetto B, Mogensen KE, Tovey MG, Gresser I (1984) Characteristics of autoantibodies to human interferon in a patient with varicella-zoster disease. J Infect Dis 150(5):707\u2013713","journal-title":"J Infect Dis"},{"issue":"9","key":"4688_CR25","doi-asserted-by":"publisher","first-page":"e2705","DOI":"10.1093\/cid\/ciaa1274","volume":"73","author":"R Ansari","year":"2021","unstructured":"Ansari R, Rosen LB, Lisco A et al (2021) Primary and acquired immunodeficiencies associated with severe varicella-zoster virus infections. Clin Infect Dis 73(9):e2705\u2013e2712","journal-title":"Clin Infect Dis"},{"key":"4688_CR26","unstructured":"Gervais A, Rovida F, Avanzini MA et al (2023) Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in approximately 40% of patients. J Exp Med 220(9):e20230661"},{"issue":"3","key":"4688_CR27","doi-asserted-by":"publisher","first-page":"e13116","DOI":"10.1111\/irv.13116","volume":"17","author":"F Alotaibi","year":"2023","unstructured":"Alotaibi F, Alharbi NK, Rosen LB et al (2023) Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta-1b in MIRACLE clinical trial. Influenza Other Respir Viruses 17(3):e13116","journal-title":"Influenza Other Respir Viruses"},{"key":"4688_CR28","doi-asserted-by":"crossref","unstructured":"Bastard P, Michailidis E, Hoffmann HH et al (2021) Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine. J Exp Med 218(4):e20202486","DOI":"10.1084\/jem.20202486"},{"issue":"7","key":"4688_CR29","doi-asserted-by":"publisher","first-page":"e3001709","DOI":"10.1371\/journal.pbio.3001709","volume":"20","author":"I Busnadiego","year":"2022","unstructured":"Busnadiego I, Abela IA, Frey PM et al (2022) Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease. PLoS Biol 20(7):e3001709","journal-title":"PLoS Biol"},{"issue":"12","key":"4688_CR30","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1136\/ard-2022-222549","volume":"81","author":"A Mathian","year":"2022","unstructured":"Mathian A, Breillat P, Dorgham K et al (2022) Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-alpha. Ann Rheum Dis 81(12):1695\u20131703","journal-title":"Ann Rheum Dis"},{"key":"4688_CR31","doi-asserted-by":"publisher","first-page":"108851","DOI":"10.1016\/j.clim.2021.108851","volume":"231","author":"I Hetemaki","year":"2021","unstructured":"Hetemaki I, Laakso S, Valimaa H et al (2021) Patients with autoimmune polyendocrine syndrome type 1 have an increased susceptibility to severe herpesvirus infections. Clin Immunol 231:108851","journal-title":"Clin Immunol"},{"key":"4688_CR32","doi-asserted-by":"crossref","unstructured":"Bastard P, Vazquez S, Liu J et al (2022) Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs. Sci Immunol 0:eabp8966","DOI":"10.1126\/sciimmunol.abp8966"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-023-04688-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-023-04688-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-023-04688-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T05:08:02Z","timestamp":1700024882000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-023-04688-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,23]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["4688"],"URL":"https:\/\/doi.org\/10.1007\/s10096-023-04688-5","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,23]]},"assertion":[{"value":"14 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics committee approval for this study was waived because it is a single-case study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The participant has consented to the submission of the case report to the journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}